Strategies for the prevention of type 2 diabetes

Experimental and Clinical Endocrinology and Diabetes

Volumn 109, Issue SUPPL. 2, 2001, Pages

  Pfohl, M ^a   Schatz, H ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Acarbose; Diet; Exercise; Glitazones; Metformin; Obesity; Prevention; Sulfonylureas; Type 2 diabetes mellitus; Weight reduction

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE INHIBITOR; BIGUANIDE DERIVATIVE; METFORMIN; PIOGLITAZONE; ROSIGLITAZONE; SULFONYLUREA DERIVATIVE; THIAZOLIDINE DERIVATIVE; TROGLITAZONE;

ARTICLE; BEHAVIOR MODIFICATION; DIET; DRUG EFFICACY; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT INDICATION;

DIABETES MELLITUS, TYPE 2; HUMANS; PREVENTIVE MEDICINE; RISK FACTORS;

EID: 0034978526     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-18585     Document Type: Article

References (53)

1. The rising global burden of diabetes and its complications: Estimates and projections to the year 2010
2. TRIPOD (TRoglitazone In the Prevention Of Diabetes): A randomized, placebo-controlled trial of troglitazone in women with prior gestational diabetes mellitus
3. Metformin
4. The United Kingdom Prospective Diabetes Study (UKPDS). Implications for the pharmacotherapy of type 2 diabetes mellitus
5. The progressive cost of complications in type 2 diabetes mellitus
6. Prevention of type 2 diabetes: Role of metformin
7. Effect of weight change and metformin on fibrinolysis and the von Wille-brand factor in obese nondiabetic subjects: The BIGPRO 1 Study
8. The STOP-NIDDM Trial: An international study on the efficacy of an alpha-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: Rationale, design, and preliminary screening data
9. Risk and prevention of type 2 diabetes in women with gestational diabetes
10. Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus
11. Lessening the burden of diabetes. Intervention strategies
12. Prevention of type 2 diabetes in subjects with impaired glucose tolerance: The Diabetes Prevention Study (DPS) in Finland
13. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study
14. Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations
15. The effect of metformin on the metabolic abnormalities associated with upper-body fat distribution
16. Clinical efficacy of new thiazolidinediones and glinides in the treatment of type 2 diabetes mellitus
17. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: The Whitehall study
18. If diabetes is a public health problem, why not treat it as one? A population-based approach to chronic illness
19. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
20. The Fasting Hyperglycaemia Study: I. Subject identification and recruitment for a non-insulin-dependent diabetes prevention trial
21. Worsening to diabetes in men with impaired glucose tolerance ("borderline diabetes")
22. Risk factors for worsening to diabetes in subjects with impaired glucose tolerance
23. Diabetes and cardiovascular risk factors: The Framingham study
24. The ten-year follow-up of the Bedford survey (1962-1972): Glucose tolerance and diabetes
25. Insulin resistance and the prevention of diabetes mellitus
26. Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections
27. Preventive medicine for our ailing health care system
28. Metformin decreases food consumption and induces weight loss in subjects with obesity with type 2 non-insulin-dependent diabetes
29. Effect of metformin on patients with impaired glucose tolerance
30. A primary intervention program (pilot study) for Mexican American children at risk for type 2 diabetes
31. Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults
32. Early presentation of type 2 diabetes in Mexican-American youth
33. Physical activity in the prevention of non-insulin-dependent diabetes mellitus
34. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance
35. Long-term changes of body weight and cardiovascular risk factors after weight reduction with group therapy and dexfenfluramine
36. Strategy of prevention: Lessons from cardiovascular disease
37. Health care expenditures for people with diabetes mellitus, 1992
38. Ten-year follow-up of subjects with impaired glucose tolerance: Prevention of diabetes by tolbutamide and diet regulation
39. The effect of dimethylbiguanide on glucose tolerance, serum insulin and growth hormone in obese patients
40. Risk factors for the development of type 2 diabetes among men enrolled in the usual care group of the Multiple Risk Factor Intervention Trial
41. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial
42. Metabolic effects of metformin in noninsulin-dependent diabetes mellitus
43. The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes
44. Development of a primary prevention program: Insight gained in the Zuni Diabetes Prevention Program
45. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
46. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
47. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
48. Epidemiology of NIDDM in Europids
49. Weight change and duration of overweight and obesity in the incidence of type 2 diabetes
50. Lifestyle intervention in overweight individuals with a family history of diabetes
51. The changing face of macrovascular disease in non-insulin dependent diabetes mellitus in different cultures: An epidemic in progress
52. Clinical efficacy of metformin against insulin resistance parameters: Sinking the iceberg
53. Globalization, coca-colonization and the chronic disease epidemic: Can the Doomsday scenario be averted?